Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Association of Motoric Cognitive Risk with White Matter Hyperintensities and Microstructural Properties
Aging, Dementia, and Behavioral Neurology
Aging and Dementia Posters (7:00 AM-5:00 PM)
089
To examine the relationship between motoric cognitive risk (MCR) syndrome and white matter (WM) structural properties.     

MCR, characterized by slow gait speed and subjective cognitive complaints, has been associated with dementia risk; however, the degree to which WM hyperintensities (WMHs) and alterations in WM microstructure occur in individuals with MCR remains unclear. Whether MCR exhibits a pattern of neuropathological changes distinct from mild cognitive impairment (MCI) is also unknown.

Nondemented participants in the Atherosclerosis Risk in Communities study (N=1591) were classified as MCR+/- based on information from a memory questionnaire and 4-meter walk. MCI+/- status was classified by expert diagnosis using standardized criteria; MCR+ and MCI+ groups overlapped. Participants underwent a 3T brain MRI to quantify WMH volume (cm3); diffusion tensor imaging (DTI) sequences quantified WM microstructural measures using a WM atlas. Multivariable linear regression, adjusted for demographic variables, quantified differences in neuroimaging characteristics, comparing MCR+ and MCI+ groups to MCR- and MCI-, respectively, in separate models.

Among 1591 participants (mean age = 75.9 years; 60.1% women, 27.8% Black, 4.5% MCR+, 34.4% MCI+) both MCR+ and MCI+ statuses were independently associated with greater WMH volume compared to MCR- and MCI- groups, respectively. The MCR associated increase in WMHs (β=0.289, 95% CI: 0.116, 0.542) was over double (143% greater than) that associated with MCI (β=0.119; 95% CI: 0.026, 0.245). MCR+ and MCI+ were associated with WM alterations in commissural, association, and projection tracts. Although individuals with MCR and MCI exhibited similar WM microstructural alterations in the corpus callosum, increased WM abnormalities were observed in several association and projection tracts—including the superior fronto-occipital fasciculus and posterior limb of the internal capsule, respectively—among individuals with MCR.

MCR may represent a clinical manifestation of white matter dysfunction or other brain changes associated with cerebral small vessel disease. 

Authors/Disclosures
Gabriela T. Gomez
PRESENTER
Ms. Gomez has nothing to disclose.
Rebecca F. Gottesman, MD, PhD (Johns Hopkins University) The institution of Dr. Gottesman has received research support from NIH.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Marilyn Albert (Johns Hopkins School of Medicine) Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Chair with Global Council on Brain Health.
David S. Knopman, MD, FÂé¶¹´«Ã½Ó³»­ (Mayo Clinic) Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Clifford R. Jack, Jr., MD (Mayo Clinic) The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
No disclosure on file
No disclosure on file